ASRS
RAPP

Arizona State Retirement System’s Rapport Therapeutics RAPP Stock Holding History

Arizona State Retirement System’s Portfolio RAPP Stock Details RAPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$316K Sell
7,584
-270
-3% -$9.92K ﹤0.01% 1776
2026
Q1 		$246K Buy
7,854
+128
+2% +$3.6K ﹤0.01% 1814
2025
Q4 		$234K Buy
+7,726
New +$214K ﹤0.01% 1858

Other funds holding RAPP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TGV
TRV GP V Boston, Massachusetts $498M AUM 267.53% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Arizona State Retirement System's RAPP Position: Q2 2026 in Review

Arizona State Retirement System reduced its Rapport Therapeutics (RAPP) stake by 3.4% in Q2 2026, selling an estimated $9.92K and leaving 7,584 shares worth $316K. The position accounts for ﹤0.01% of the portfolio, ranked #1776.

Arizona State Retirement System first reported a position in RAPP in Q4 2025 and has held it in 3 quarters since. 161 funds tracked by Wall St. Rank hold RAPP as of Q2 2026.

  • Arizona State Retirement System held 7,584 shares of Rapport Therapeutics worth $316K as of Q2 2026.
  • Arizona State Retirement System sold 270 Rapport Therapeutics shares in Q2 2026, an estimated $9.92K.
  • Rapport Therapeutics made up ﹤0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #1776 holding.
  • Arizona State Retirement System first reported a position in Rapport Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 161 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.